298 related articles for article (PubMed ID: 10900013)
1. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells.
Biswas DK; Cruz AP; Gansberger E; Pardee AB
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8542-7. PubMed ID: 10900013
[TBL] [Abstract][Full Text] [Related]
2. [The nuclear factor kappa B activation: the key step of cell proliferation in estrogen receptor-negative breast cancer cells].
Wang HJ; Wu ZY; Fan P; Bian JM
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):1014-6. PubMed ID: 16194364
[TBL] [Abstract][Full Text] [Related]
3. The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers.
Biswas DK; Dai SC; Cruz A; Weiser B; Graner E; Pardee AB
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10386-91. PubMed ID: 11517301
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.
Singh S; Shi Q; Bailey ST; Palczewski MJ; Pardee AB; Iglehart JD; Biswas DK
Mol Cancer Ther; 2007 Jul; 6(7):1973-82. PubMed ID: 17620428
[TBL] [Abstract][Full Text] [Related]
5. RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling.
Sirinian C; Papanastasiou AD; Schizas M; Spella M; Stathopoulos GT; Repanti M; Zarkadis IK; King TA; Kalofonos HP
Oncogene; 2018 Sep; 37(37):5101-5114. PubMed ID: 29844572
[TBL] [Abstract][Full Text] [Related]
6. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
Zhang X; Diaz MR; Yee D
Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
[TBL] [Abstract][Full Text] [Related]
7. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.
Biswas DK; Iglehart JD
J Cell Physiol; 2006 Dec; 209(3):645-52. PubMed ID: 17001676
[TBL] [Abstract][Full Text] [Related]
8. NF-κB-dependent transcriptional upregulation of cyclin D1 exerts cytoprotection against hypoxic injury upon EGFR activation.
Chen ZD; Xu L; Tang KK; Gong FX; Liu JQ; Ni Y; Jiang LZ; Hong J; Han F; Li Q; Yang XH; Sun RH; Mo SJ
Exp Cell Res; 2016 Sep; 347(1):52-59. PubMed ID: 27443256
[TBL] [Abstract][Full Text] [Related]
9. ABINs inhibit EGF receptor-mediated NF-kappaB activation and growth of EGF receptor-overexpressing tumour cells.
Huang L; Verstrepen L; Heyninck K; Wullaert A; Revets H; De Baetselier P; Beyaert R
Oncogene; 2008 Oct; 27(47):6131-40. PubMed ID: 18622428
[TBL] [Abstract][Full Text] [Related]
10. A switch role of Src in the biphasic EGF signaling of ER-negative breast cancer cells.
Zhang X; Meng J; Wang ZY
PLoS One; 2012; 7(8):e41613. PubMed ID: 22927910
[TBL] [Abstract][Full Text] [Related]
11. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
Siraj MA; Jacobs AT; Tan GT
Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor activates nuclear factor-kappaB in human proximal tubule cells.
Häussler U; von Wichert G; Schmid RM; Keller F; Schneider G
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F808-15. PubMed ID: 15798085
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor protects squamous cell carcinoma against cisplatin-induced cytotoxicity through increased interleukin-1β expression.
Ko SC; Huang CR; Shieh JM; Yang JH; Chang WC; Chen BK
PLoS One; 2013; 8(2):e55795. PubMed ID: 23383347
[TBL] [Abstract][Full Text] [Related]
16. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NF-kappa B activation and its target genes by heparin-binding epidermal growth factor-like growth factor.
Mehta VB; Besner GE
J Immunol; 2003 Dec; 171(11):6014-22. PubMed ID: 14634113
[TBL] [Abstract][Full Text] [Related]
18. CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.
Jiang T; Grabiner B; Zhu Y; Jiang C; Li H; You Y; Lang J; Hung MC; Lin X
Cancer Res; 2011 Mar; 71(6):2183-92. PubMed ID: 21406399
[TBL] [Abstract][Full Text] [Related]
19. Linear Ubiquitination Mediates EGFR-Induced NF-κB Pathway and Tumor Development.
Hua F; Hao W; Wang L; Li S
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769306
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation.
Van Laere SJ; Van der Auwera I; Van den Eynden GG; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
Br J Cancer; 2007 Sep; 97(5):659-69. PubMed ID: 17700572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
